Central Pacific Bank Trust Division Has $1.85 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Central Pacific Bank Trust Division trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 27.1% during the 4th quarter, HoldingsChannel reports. The fund owned 3,665 shares of the healthcare conglomerate’s stock after selling 1,359 shares during the quarter. Central Pacific Bank Trust Division’s holdings in UnitedHealth Group were worth $1,854,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of UNH. State Street Corp lifted its stake in UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after purchasing an additional 563,554 shares during the period. Geode Capital Management LLC increased its position in UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after acquiring an additional 318,039 shares in the last quarter. Franklin Resources Inc. boosted its position in UnitedHealth Group by 2.5% in the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock valued at $4,884,019,000 after buying an additional 193,800 shares during the last quarter. International Assets Investment Management LLC raised its stake in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after buying an additional 880,183 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH traded up $9.74 on Friday, hitting $514.25. The company’s stock had a trading volume of 1,511,461 shares, compared to its average volume of 2,838,250. The firm has a market cap of $473.26 billion, a P/E ratio of 33.50, a price-to-earnings-growth ratio of 1.53 and a beta of 0.58. The company’s 50 day simple moving average is $560.86 and its 200-day simple moving average is $560.03. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter last year, the company earned $6.56 EPS. The firm’s revenue was up 9.2% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.63%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is 54.72%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. TD Cowen upped their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Bank of America decreased their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Oppenheimer upped their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Finally, Cantor Fitzgerald boosted their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $628.37.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.